Prilocaine

Prilocaine
Clinical data
Trade names	Citanest
AHFS/Drugs.com	Monograph
MedlinePlus	a603026
License data	EU EMA: by INN; US DailyMed: Prilocaine;
Pregnancy; category	AU: A;
Routes of; administration	Subcutaneous
ATC code	N01BB04 (WHO) ;
Legal status
Legal status	AU: S4 (Prescription only) ; US: ℞-only ;
Pharmacokinetic data
Protein binding	55%
Metabolism	Liver and kidney
Elimination half-life	10-150 minutes, longer with impaired liver or kidney function
Identifiers
	IUPAC name (RS)-N-(2-methylphenyl)-N2-propylalaninamide;
CAS Number	721-50-6 ;
PubChem CID	4906;
IUPHAR/BPS	7276;
DrugBank	DB00750 ;
ChemSpider	4737 ;
UNII	046O35D44R;
KEGG	D00553 ; as HCl: D01243 ;
ChEBI	CHEBI:8404 ;
ChEMBL	ChEMBL1194 ;
CompTox Dashboard (EPA)	DTXSID7031955 ;
ECHA InfoCard	100.010.871
Chemical and physical data
Formula	C13H20N2O
Molar mass	220.316 g·mol−1
3D model (JSmol)	Interactive image;
Chirality	Racemic mixture
Melting point	37 to 38 °C (99 to 100 °F)
	SMILES O=C(Nc1ccccc1C)C(NCCC)C;
	InChI InChI=1S/C13H20N2O/c1-4-9-14-11(3)13(16)15-12-8-6-5-7-10(12)2/h5-8,11,14H,4,9H2,1-3H3,(H,15,16) ; Key:MVFGUOIZUNYYSO-UHFFFAOYSA-N ;
	(verify)

Prilocaine (/ˈpraɪləˌkeɪn/[1]) is a local anesthetic of the amino amide type first prepared by Claes Tegner and Nils Löfgren. In its injectable form (trade name Citanest), it is often used in dentistry. It is also often combined with lidocaine as a topical preparation for dermal anesthesia (lidocaine/prilocaine or EMLA), for treatment of conditions like paresthesia. As it has low cardiac toxicity, it is commonly used for intravenous regional anaesthesia (IVRA).

Contraindications

In some patients, ortho-toluidine, a metabolite of prilocaine, may cause methemoglobinemia, which may be treated with methylene blue. Prilocaine may also be contraindicated in people with sickle cell anemia, anemia, or symptomatic hypoxia.[2]

Combinations

It is given as a combination with the vasoconstrictor epinephrine under the trade name Citanest Forte. It is used as an eutectic mixture with lidocaine, 50% w/w, as lidocaine/prilocaine. The mixture is an oil with a melting point of 18 °C (64 °F). A 5% emulsion preparation, containing 2.5% each of lidocaine/prilocaine, is marketed by APP Pharmaceuticals under the trade name EMLA (an abbreviation for eutectic mixture of local anesthetics).[3]

Compendial status

United States Pharmacopeia 31 [4]

References

"Prilocaine". Merriam-Webster Dictionary. Retrieved 2016-01-21.
Patel V, Morrissey J (2011-09-15). Practical and Professional Clinical Skills. Oxford University Press. p. 267. ISBN 9780199585618.
"Topical Anesthesia Use in Children: Eutectic Mixture of Local Anesthetics". Medscape.com. Retrieved 2014-01-07.
The United States Pharmacopeial Convention, Revision Bulletin: Lidocaine and Prilocaine Cream–Revision to Related Compounds Test, archived from the original on 5 July 2010, retrieved 10 July 2009

External links

"Prilocaine". Drug Information Portal. U.S. National Library of Medicine.
"Prilocaine hydrochloride". Drug Information Portal. U.S. National Library of Medicine.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] "Prilocaine". Merriam-Webster Dictionary. Retrieved 2016-01-21.

[2] Patel V, Morrissey J (2011-09-15). Practical and Professional Clinical Skills. Oxford University Press. p. 267. ISBN 9780199585618.

[3] "Topical Anesthesia Use in Children: Eutectic Mixture of Local Anesthetics". Medscape.com. Retrieved 2014-01-07.

[rblp-4] The United States Pharmacopeial Convention, Revision Bulletin: Lidocaine and Prilocaine Cream–Revision to Related Compounds Test, archived from the original on 5 July 2010, retrieved 10 July 2009